Challenges facing JAK inhibitor therapy for myeloproliferative neoplasms

Ayalew Tefferi

doi:10.1056/NEJMe1115119

Challenges facing JAK inhibitor therapy for myeloproliferative neoplasms

Ayalew Tefferi

Hematology

Research output: Contribution to journal › Editorial › peer-review

48 Scopus citations

Original language	English (US)
Pages (from-to)	844-846
Number of pages	3
Journal	New England Journal of Medicine
Volume	366
Issue number	9
DOIs	https://doi.org/10.1056/NEJMe1115119
State	Published - Mar 1 2012

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1056/NEJMe1115119

Cite this

@article{9262c7cbc88b4c159bbab348c70a6f5b,

title = "Challenges facing JAK inhibitor therapy for myeloproliferative neoplasms",

author = "Ayalew Tefferi",

year = "2012",

month = mar,

day = "1",

doi = "10.1056/NEJMe1115119",

language = "English (US)",

volume = "366",

pages = "844--846",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "9",

}

TY - JOUR

T1 - Challenges facing JAK inhibitor therapy for myeloproliferative neoplasms

AU - Tefferi, Ayalew

PY - 2012/3/1

Y1 - 2012/3/1

UR - http://www.scopus.com/inward/record.url?scp=84857828112&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857828112&partnerID=8YFLogxK

U2 - 10.1056/NEJMe1115119

DO - 10.1056/NEJMe1115119

M3 - Editorial

C2 - 22375977

AN - SCOPUS:84857828112

SN - 0028-4793

VL - 366

SP - 844

EP - 846

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 9

ER -

Challenges facing JAK inhibitor therapy for myeloproliferative neoplasms

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this